title: Membranous nephropathy associated with fluconazole treatment.
abstract: About 6% to 9% of cases of membranous nephropathy develop secondary to exposure to drugs. Fluconazole is a widely used antifungal agent that was never implicated in the development of membranous nephropathy. We report the case of a patient found to have membranous nephropathy secondary to fluconazole treatment. This patient had recurrent episodes of nephrotic syndrome caused by readministration of fluconazole. This is the first reported case of membranous nephropathy caused by fluconazole treatment and the first case report of the clinical course of recurrent membranous nephropathy caused by reexposure to this medication.
authors.affiliation: Department of Nephrology, Ajou University School of Medicine, Suwon, Korea. gtshin@ajou.ac.kr
authors.forename: Gyu-Tae
authors.initials: GT
authors.lastname: Shin
authors.forename: Hyunee
authors.initials: H
authors.lastname: Yim
authors.forename: Jieun
authors.initials: J
authors.lastname: Park
authors.forename: Heungsoo
authors.initials: H
authors.lastname: Kim
mesh_terms: D005260:Female; D015725:Fluconazole / Q000009:adverse effects*; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008875:Middle Aged
chemical_list: D015725:Fluconazole